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Studying protein production is important for fundamental research on cell biology and applied research
for biotechnology. Yeast Saccharomyces cerevisiae is an attractive workhorse for production of re-
combinant proteins as it does not secrete many endogenous proteins and it is therefore easy to purify a
secreted product. However, recombinant production at high rates represents a signiﬁcant metabolic
burden for the yeast cells, which results in oxidative stress and ultimately affects the protein production
capacity. Here we describe a method to reduce the overall oxidative stress by overexpressing the en-
dogenous HAP1 gene in a S. cerevisiae strain overproducing recombinant α-amylase. We demonstrate
how Hap1p can activate a set of oxidative stress response genes and meanwhile contribute to increase
the metabolic rate of the yeast strains, therefore mitigating the negative effect of the ROS accumulation
associated to protein folding and hence increasing the production capacity during batch fermentations.
& 2016 The Authors. Published by Elsevier B.V. International Metabolic Engineering Society. This is an
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
Proteins are essential cellular components and play many roles
in cell physiology, such as scaffolding cell structures, catalysis,
signaling, transport and gene expression regulation. Investigating
and assessing these roles often requires a deep understanding of
protein structure and activity which demands sufﬁcient quantities
of the puriﬁed protein, which in many cases needs to be produced
heterologously (Bill, 2014). Apart from fundamental research, re-
combinant protein production also represents a multi-billion
dollar market (Martinez et al., 2012), due to the use of proteins as
biopharmaceuticals and industrial enzymes, e.g. anti-TNF and
cancer antibodies, insulin analogs and proteases among others,
constituting about 50–60% of the total market (Demain and
Vaishnav, 2009; Huang et al., 2014).
Escherichia coli is predominantly used as host for commercial
production and research (Mattanovich et al., 2012), mainly be-
cause it is easy to cultivate and manipulate, due to the large
number of molecular tools and genetic information available and,
more importantly, due to the fact that the recombinant protein
fraction in this organism can reach up to 50% of the dry biomass
(Porro et al., 2011). There are, however, important drawbacks ofr B.V. International Metabolic Engi
and Biological Engineering,
296 Göteborg, Sweden.using E. coli as a production platform for proteins, for example
increased downstream processing costs due to the formation of
inclusion bodies (Sorensen, 2010) and lack of correct posttransla-
tional modiﬁcations of eukaryal proteins (Ferrer-Miralles et al.,
2009). As an alternative, yeasts including Saccharomyces cerevisiae,
are being increasingly used as the preferred platform for protein
production. Yeasts have all the advantages of a microbial system
(easy of manipulation and cultivation) and possess eukaryal post-
translational machinery (Bill, 2014). Furthermore, the recombinant
proteins can be secreted to the extracellular medium, thus facil-
itating subsequent puriﬁcation (Nielsen, 2013).
However, one of the limitations of using yeast as a production
platform is the burden that secreting proteins at higher rates may
represent for cell metabolism, especially for the endoplasmic re-
ticulum (ER), since protein folding is a very crucial step of the
secretory pathway: a correct folding determines if the newly
synthesized protein is targeted for secretion, otherwise it will be
assigned for ER-associated degradation (ERAD) (Schroder, 2008).
Thus, larger and more complex proteins produced at high levels
often result in induction of ER-stress, and these conditions in the
secretory pathway have consequences for the whole cell (Tu and
Weissman, 2004). In many cases, protein folding includes disulﬁde
bonds formation, which in eukaryotes is managed by a co-
ordinated action of protein disulﬁde isomerases (PDI) and Ero1p,
using molecular oxygen as the terminal electron acceptor (Tu et al.,
2000), hence generating reactive oxygen species (ROS). Often
during this process, non-native disulﬁde bonds are formed, whichneering Society. This is an open access article under the CC BY license
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correct ones, resulting in increased amounts of intracellular ROS.
The outcome may be worse if the protein has an odd number of
cysteine residues, because it may trigger a futile cycle that leads to
oxidative stress (Tyo et al., 2012). Nevertheless, the link between
high rates of recombinant protein production and oxidative stress
is not just restricted to proteins containing disulﬁde bonds. Het-
erologous proteins that are overexpressed need folding assistance
even if they do not form disulﬁde bonds and this can sequester the
folding capacity in the ER, creating misfolding of homologous
proteins which can limit the efﬁciency of protein synthesis and
result in ROS accumulation (Tyo et al., 2012). Thus, as a rule of
thumb, production of secreted heterologous proteins will often
generate oxidative stress, regardless of the target protein.
It is generally believed that alleviating ER stress might result in
an improved secretion of a desired protein. Thus, several such
strategies have been pursued as, for example, overexpression of
protein disulﬁde isomerases (Robinson et al., 1994) or heat shock
proteins acting as chaperones for the folding process (Hou et al.,
2013; 2014). However, even considering that these strategies in-
creased the secretion efﬁciency, they did not address in detail the
problem of ROS accumulation, which still remains high, and the
induction of the oxidative stress response.
In the yeast S. cerevisiae, aerobic metabolism is managed by a
single transcription factor, encoded by HAP1. Hap1p is responsible
for the activation of the respiratory metabolism in response to
environmental oxygen levels, via heme signaling, as well as the
activation of a cluster of oxidative stress responsive genes (Zhang
and Hach, 1999), which has been previously reported to be a key
player concerning heterologous protein production and regulation
of stress levels in yeast systems (Yu et al., 2010; Martinez et al.,
2015).
Here we describe a strategy to reduce overall ROS levels while
producing proteins at high rates. To achieve this, we chose to
overexpress HAP1 in a S. cerevisiae strain overproducing re-
combinant α-amylase, since this protein has been already suc-
cessfully used as a model to identify targets for further engineer-
ing the secretory pathway and it is known to induce oxidative
stress (Tyo et al., 2012; Hou et al., 2014).2. Materials and methods
2.1. Yeast strains
For this study, the S. cerevisiae strain CENPK.530–1D producing
recombinant α-amylase (Liu et al., 2012) was transformed with the
plasmid pRS426 (Hou et al., 2012) overexpressing HAP1, cloned
into the BamHI/SpeI sites, downstream the constitutive TEF pro-
moter. The HAP1 gene sequence was obtained by PCR using S.





The 5′ end of the reverse primer additionally includes a DNA
tail (underlined 51 nucleotides) corresponding to the N-terminal
of Hap1p inferred from the S. cerevisiae W303 strain amino acid
sequence, reported as the most efﬁcient version of Hap1 among all
the S. cerevisiae subtypes (Gaisne et al., 1999). Two clones, namely
JLM-1 and JLM-2, were selected for further characterization and
analysis.2.2. Physiological characterization in shake ﬂasks and bioreactors
Yeast seed cultures were prepared from fresh individual co-
lonies on agar plates and grown in shake ﬂasks (250 ml) con-
taining liquid YPD supplemented with 2% glucose, overnight, at
30 °C with constant shaking (200 rpm). Batch and chemostat cul-
tures were performed in stirred bioreactors (DASGIP Parallel
Bioreactor Systems), yeast pre-cultures inoculated at an initial OD
of 0.05 into a ﬁnal volume of 500 ml of liquid SD ura his(6.7 g/L
YNB without aminoacids þ0.75 g/L supplement mix without ur-
acil and histidine, Formedium), containing 2% glucose as carbon
source, 2 g/L KH2PO4, 1 g/L Bovine Serum Albumin (Sigma) and
supplemented with 2XSCAA solution (Wittrup and Benig, 1994).
Batch cultures were performed keeping a constant temperature
of 30 °C, 600 rpm agitation, standard 1 vvm air ﬂow (21% oxygen
blend) and pH controlled at 6 by KOH (2 M). Dissolved oxygen was
controlled above 30% using a polarographic oxygen electrode
(Mettler Toledo, Switzerland). Real time exhaust oxygen and car-
bon dioxide values during cultivations were measured by using a
DASGIP GA4 analyzer linked to the bioreactor vessels.
Chemostat cultivations were performed at dilution rates of
0.1 and 0.2 h1. The feeding phase (carbon limited, 1% glucose)
was initiated right after the remaining ethanol from the batch
fermentation was exhausted, and 5 resident times were needed to
reach steady state continuous cultivation. All fermentations were
done in biological triplicates.
2.3. Analytical methods for measuring the exometabolome, secreted
amylase and intracellular heme
The dry cell weight was obtained by ﬁltering 5 ml of cell culture
through 0.45 mm ﬁlters (Sartorius). Throughout the cultivation
process, concentrations of glucose, glycerol, ethanol and acetate
were analyzed by HPLC (Ultimate 3000, Dionex) equipped with an
Aminex HPX-87 h column (Biorad) at 65 °C, using 5 mM H2SO4 as
the mobile phase and a ﬂow rate of 0.6 ml/min.
For the secreted amylase measurements, cells were pelleted by
centrifugation from 1 ml of culture broth and the supernatant was
taken to determine the amylase concentration by spectro-
photometry with the Ceralpha kit (Megazyme), using α-amylase
from Aspergillus oryzae (Sigma) as standard.
The relative concentration of intracellular heme was de-
termined as described by (Liu et al., 2014). Brieﬂy, an amount of
cells corresponding to OD600¼8 were harvested from the culture,
pelleted by centrifugation, resuspended in 500 ml of oxalic acid
(20 mM) and stored overnight at 4 °C in an amber tube in dark.
Just before the measurement, additional 500 ml of oxalic acid (2 M)
was added to each sample, and half of the mixture was taken apart
and kept at room temperature whereas the other half was heated
up to 95 °C for 30 min. Then 200 ml of clear supernatant was
transferred to a 96-well plate to measure the ﬂuorescence (ex-
citation at 400 nm, emission at 600 nm), total heme levels corre-
sponding to the heated samples and free heme to the non-heated
samples.
2.4. Assessment of gene transcription using real time qPCR
Samples for RNA extraction were taken during exponential
phase (batch fermentation) and steady state (chemostat cultiva-
tion). Yeast biomass corresponding to 2107 cells was harvested
by centrifugation at 12000xg for the RNA extraction using the
RNeasys kit from QIAGEN according to the manufacturer's in-
structions. A DNAase treatment was performed to remove all
traces of remaining genomic DNA (Udvardi et al., 2008; Nolan
et al., 2006; Bustin et al., 2009). To assess the concentration and
quality of the RNA, the nanodrop 2000 spectrophotometer was
Table 1
Physiological characterization of the α-amylase producing strains during batch
fermentation in bioreactors.
Strains mmaxa (h1) YSEb YSGb YSAb
Control 0.31 0.32 0.09 0.01
JLM-1 0.35 0.27 0.1 0.01
JLM-2 0.4 0.21 0.07 0.02
Average values from three independent biological replicates for each strain are
shown. The calculated standard error calculated for all the cases was less than 3%.
a Maximum speciﬁc growth rate (h1) on glucose.
b Yield of ethanol (E), glycerol (G) and acetate (A) from glucose (S) (g/g).
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280 nm (protein) and 230 nm (carbohydrates and other con-
taminants) (Becker et al., 2010). In order to verify the RNA de-
gradation status in the samples, a 1% agarose gel was used to vi-
sualize the 28S, 18S and 5S ribosomal RNA bands. The RNA con-
centration was set to 500 ng/ml with RNAase-free water and 10 ml
were used for ﬁrst strand cDNA synthesis using the Quantitec kit
from QIAGEN following the manufacturer's recommendations.
Primers for the test genes were designed using the primer3 soft-
ware (Rozen and Skaletsky, 2000). The validation of the primers
was done with serial 10-fold dilutions of the cDNA and then the
qPCR was performed including a melting curve test. The primer
dimers existence and the efﬁciency of the PCR reaction were de-
termined (Ruijter et al., 2009; Schefe et al., 2006). The gene ARG2
was used as a reference gene. The genes HAP1, CYC1, ROX1, SOD1
and YHB1were used to assess the transcriptional response to HAP1
overexpression.
The qPCR reactions were performed in the Mx 3005 P ther-
mocycler (Agilent technologies) using Brilliant III Ultra-Fast SYBRs
Green QPCR mix, following the manufacturer's instructions. The
threshold and the base line were set by default and the Ct obtained
using the MxPro software (Agilent). The Ct values were used to
determine the transcriptional fold changes with the ΔCt method
(Schefe et al., 2006), using as efﬁciency value the efﬁciency ob-
tained from the primer validation.
2.5. Assessing cell stress
2107 cells were harvested from the bioreactor cultures by
centrifugation. The cell pellets were resuspended and used for
staining with the Mitotracker green FM and the dihydrorhodamine
123 (DHR123) dyes for assessing the mitochondrial homeostasis
and the reactive oxygen species accumulation, respectively (Mill-
ard et al., 1997; Keij et al., 2000; Qin et al., 2008).
Images from stained cells were taken on an inverted Leica AF
6000 ﬂuorescence microscope with a HCX PL APO CS 100.01.40
OIL objective, captured with a DFC 360 FX camera and the Leica
Application Suite software. The quantiﬁcation of the cells involved
the analysis of at least 300 cells per sample from three in-
dependent experiments. The brightness and the gain settings were
adjusted to avoid the background noise and to discard false posi-
tives during the counting.
For the determination of the mitochondrial and the cell wall
integrity, the cell pellet was suspended in 1 ml of HEPES buffer
(HEPES¼10 mM, glucose 5%, pH¼7.4) containing the dye mito-
tracker green FM (100 nM) (Keij et al., 2000). The cell suspension
was incubated at room temperature in dark for 15 min. After the
incubation, the cells were centrifuged at 12000xg and 2 ml of the
cell pellet was loaded on a microscope slide for inspection by
ﬂuorescence microscopy using the ﬁlters for green and red
ﬂuorescence.
The reactive oxygen species (ROS) accumulation was de-
termined by staining the cells with DHR123 (Qin et al., 2008). The
cell pellet was washed three times with water and suspended in
1 ml of sodium citrate buffer (sodium citrate 50 mM, glucose 2%,
pH¼5.0) containing DHR123 (50 mM). The cell suspension was
incubated at room temperature in dark for 15 min. After the in-
cubation, the cells were centrifuged at 12000xg and 2 ml of the cell
pellet was loaded on a microscope slide for inspection by ﬂuor-
escence microscopy using the ﬁlter for yellow ﬂuorescence.
2.6. Cell size determination
To determine the population cell size, the Guava easyCyte™ HT
System was used. The forward scatter (FSC) and the side scatter
(SSC) were used as parameters for cell size and shape respectively.The control was the strain with no overexpression of the gene
HAP1, whereas the two strains harboring the plasmid that over-
express HAP1 were treated as the experiments (referred as JLM-1
and JLM-2). Prior to the analysis, the cytometer performance was
assessed using the guava easyCheck™ Kit. The FCS 3.0 ﬁle was
converted to a FCS 2.0 ﬁle using the FCS convert utility from http://
www.guavatechsupport.com/muse/. Once converted, the FCS
2.0 ﬁle was analyzed and plotted using the ﬂowCore and the
ggplot software (Ellis et al., 2016; Wickham, 2009).3. Results and discussion
3.1. HAP1 overexpression promotes respiration in a dose-dependent
manner
Batch fermentations of S. cerevisiae strains overexpressing the
transcription factor Hap1p (JLM-1 and JLM-2), and the control
strain (empty plasmid), were performed in synthetic liquid media
using 2% glucose as carbon source. Samples were taken to estimate
the physiological parameters at different time points (Table 1), and
we found that the HAP1 overexpressing strains had a higher
growth rate and a shorter glucose consumption phase. We also
found slight differences between the two Hap1 overexpressing
clones: the clone JLM-2 had and even higher growth rate and
shorter glucose phase than the clone JLM-1 (Supplementary ﬁgure
S1). We performed RT-qPCR analysis and found that the two
clones had different expression levels of HAP1 (1.4 fold and 2.1 fold
over the control strain for JLM-1 and JLM-2 respectively), probably
due to differences in the plasmid copy number, since it is a high
copy plasmid and its number may differ among transformant
strains up to 5% (www.adgene.org). The strain with the higher
expression level of HAP1 (JLM-2) had a higher growth rate and
faster consumption both of glucose and of ethanol. Additionally,
HAP1 overexpressing strains had a lower ethanol yield (higher the
expression, lower the yield). This might indicate that increased
Hap1p levels may promote diminishment of the fermentative
metabolism (preferred by S. cerevisiae), and increased respirative
metabolism. We assessed the status of the mitochondrial network
(Fig. 1A) and found that in HAP1 overexpressing strains, the mi-
tochondrial network is larger and more developed compared with
the control strain, which is in accordance with a higher respiratory
rate. We also noticed that the size of the HAP1 overexpressing cells
is slightly bigger, which was further conﬁrmed by ﬂow cytometry
(Supplementary Fig. S2).
3.2. Hap1 promotes increased growth rates without oxidative stress
penalty during batch fermentations
Overexpression of the HAP1 gene increased the metabolic rate
of S. cerevisiae. Thus, in order to study the consequences of in-
creased respiration on oxidative stress, we determined the pro-
duction of ROS and mitochondrial damage throughout the
Fig. 1. (A) Mitochondrial network display exhibited by control and HAP1 overexpressing cells (JLM-1 and JLM-2) throughout the fermentation process as observed by
ﬂuorescence microscopy. A 10 mm scale bar is displayed for cell size reference. (B) ROS accumulation estimated (percentage of cells affected over the total cell population) for
the studied strains at different sample points during the fermentation.
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batch cultivations and samples were collected at different time
points. Results shown in Fig. 1B revealed that the levels of oxida-
tive stress in the HAP1 overexpressing strains, evidenced by the
production of ROS and the mitochondrial dysfunction, were kept
at the same level as the control strain during the ﬁrst 48 h of
cultivation. It is after this time, when a clear divergence among the
strains analyzed occurs: the transformant cells exhibit an im-
portant ROS accumulation and severe mitochondrial damage after
72 h of batch fermentation, which is even more acute after 96 h.
The amount of recombinant amylase secreted during batch by
the HAP1 overexpressing strains compared to the control strains
was also analyzed. Interestingly, the amount of recombinant pro-
tein produced by the strains JLM-1 and JLM-2, on average, almost
doubles the amount of amylase produced by the control strain:
646 U/L (average) vs. 371 U/L, respectively (Fig. 2). This increase is,
however, primarily due to the faster growth of the engineered
strain as the speciﬁc titer was about the same for the two strains
(563 U/g CDW and 561 U/g CDW for the control strain and the
JML-1 strain, respectively). The difference in the production ca-
pacity among strains still remains signiﬁcant after 48 h and per-
sists over time throughout the whole fermentation process, but
with a smaller difference at the end of the fermentation.
HAP1 overexpression could increase the growth rate by 20–25%
(Table 1) with no additional burden in ROS during the ﬁrst 48 h of
fermentation, as previously shown in Fig. 1B, allowing for higher
volumetric productivity of amylase. The transformant strains do
not suffer from oxidative stress during this period and they are
therefore able to keep a higher rate of protein production, while
the control strains show a slower metabolic rate, hence a lower
growth rate and therefore a lower protein yield. In summary, the
HAP1 strains produce more protein over time because they canFig. 2. Amylase titer calculated for the HAP1 overexpressing strains (JLM-1 and
JLM-2) compared to the control strain during batch fermentation in the bioreactors.grow faster than the control and for 48 h are unaffected by oxi-
dative stress, just before the ROS levels become unsustainable so
they start suffering from mitochondrial damage.
3.3. HAP1 overexpression enhances amylase productivity in chemo-
stat cultivations at increased dilution rates
In order to assess the oxidative stress response triggered by
Hap1p, the relative expression of a few representative genes that
are induced by this transcription factor in the oxidative stress re-
sponse, such as SOD1 and YHB1 (Zhang and Hach, 1999; Ter Linde
and Steensma, 2002), were analyzed by qPCR. The analysis also
included other genes related to the activation of the respiratory
metabolism (CYC1 and ROX1). Samples for this analysis were taken
from chemostat cultures at two different dilution rates (0.1 h1
and 0.2 h1), after ﬁve residence times (time needed for yeast
cultures to reach the steady state). In addition, the amylase con-
centration was measured and the productivity was calculated for
each strain at the given dilution rate. As shown in Fig. 3, genes
related to oxidative stress protection were overexpressed in JLM-1
and JLM-2 at both dilution rates compared to the control strain, as
well as those involved in the respiratory metabolism.
When we measured the amylase productivity, we found that at
the lower dilution rate, the control strain shows a higher value
than the HAP1 overexpressing strains (Fig. 4). However, increasing
the dilution rate results in a signiﬁcant decrease of the production
capacity for the control strain, whereas the capacity of the strains
JLM-1 and JLM-2 remains unaffected, if not slightly improved for
the case of JLM-1. From these results we might conclude that, since
both transformant strains have an increased growth rate, in-
creasing the dilution rate for the chemostat cultivation has no
negative effect because they are still far from their optimal growth
capacity (which is m¼0.4 for the best strain), whereas for the case
of the control strain, getting close to its maximum growth rate
means an increase in the metabolic rate and hence an increased
generation of ROS and oxidative stress, which ultimately affects
the amylase productivity of this strain. This negative effect on the
amylase productivity at increasing dilution rates during chemostat
cultivations was already reported by Liu et al. (2013), and the
transcriptional analysis suggested that might be related to ER
processing and global stress responses. Here we propose that
oxidative stress is a signiﬁcant contributor to this effect in aerobic
culture conditions, since higher expression levels of the relevant
protective genes controlled by Hap1p may keep the amylase pro-
ductivity levels intact.
In summary, the HAP1 overexpressing strains produce more
Fig. 3. Relative expression levels of HAP1 of the transformant strains (JLM-1 and JLM-2) and control strains and some of its target genes involved in respirative metabolism
(CYC1 and ROX1) and oxidative stress protection (SOD1 and YHB1), estimated by qPCR from samples taken during chemostat cultivation in bioreactors at two different
dilution rates (0.1 and 0.2 h-1). All the values are relative and normalized to those obtained for the control strain at D¼0.1.
Fig. 4. Amylase speciﬁc productivity for JLM-1 and JLM-2 compared to the control
strain during chemostat cultivations at different dilution rates.
J.L. Martínez et al. / Metabolic Engineering Communications 3 (2016) 205–210 209protein over time because they can grow faster than the control,
respire more efﬁciently, and are less affected by oxidative stress
and mitochondrial damage due to the continuous induction of the
oxidative stress response.4. Conclusion
Regardless the type of protein being over-expressed, high rates
of protein production represent a metabolic burden for yeast cells,
which implicates several kinds of cell stress, including oxidative
stress which results in ROS generation. In order to reduce the
negative effect of oxidative stress we generated two different
strains over-expressing the transcription factor Hap1p, which ac-
tivates several oxidative stress response genes. This induced the
oxidative stress response and at the same time increased the
metabolic capacity (growth rate and respiration) of S. cerevisiae.
Moreover, the strategy of increasing oxidative stress response by
over-expression of HAP1 allows increased productivity both in
batch cultures and in chemostats, which can be operated at a
higher dilution rate. The results of our work therefore conﬁrm that
there is a direct link between oxidative stress and the recombinant
protein production capacity in S. cerevisiae, and that the negative
effects caused by the increased metabolic burden triggered by
protein over-expression can be signiﬁcantly mitigated simply by
the enhancement of the molecular mechanisms already present in
the cell.Acknowledgements
This work has been funded by the Novo Nordisk Foundation,
Knut and Alice Wallenberg Foundation and FORMAS.Appendix A. Supporting information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.meteno.2016.06.
003.References
Becker, C., Hammerle-Fickinger, A., Riedmaier, I., Pfafﬂ, M.W., 2010. mRNA and
microRNA quality control for RT-qPCR analysis. Methods 50 (4), 237–243.
Bill, R.M., 2014. Playing catch-up with Escherichia coli: using yeast to increase
success rates in recombinant protein production experiments. Front Microbiol.
5, 85.
Bustin, S.A., Benes, V., Garson, J.A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R.,
Nolan, T., Pfafﬂ, M.W., Shipley, G.L., et al., 2009. The MIQE guidelines: minimum
information for publication of quantitative real-time PCR experiments. Clin.
Chem. 55 (4), 611–622.
Demain, A.L., Vaishnav, P., 2009. Production of recombinant proteins by microbes
and higher organisms. Biotechnol. Adv. 27 (3), 297–306.
Ellis B., Haaland, P., Hahne, F., Le Meur, N., Gopalakrishnan, N., Spidlen, J. 2016. Basic
structures for ﬂow cytometry data. In: ﬂowCore. R Software.
Ferrer-Miralles, N., Domingo-Espin, J., Corchero, J.L., Vazquez, E., Villaverde, A.,
2009. Microbial factories for recombinant pharmaceuticals. Microb. Cell Fact. 8,
17.
Gaisne, M., Becam, A.M., Verdiere, J., Herbert, C.J., 1999. A 'natural’ mutation in
Saccharomyces cerevisiae strains derived from S288c affects the complex reg-
ulatory gene HAP1 (CYP1). Curr. Genet. 36 (4), 195–200.
Hou, J., Tyo, K., Liu, Z., Petranovic, D., Nielsen, J., 2012. Engineering of vesicle traf-
ﬁcking improves heterologous protein secretion in Saccharomyces cerevisiae.
Metab. Eng. 14 (2), 120–127.
Hou, J., Osterlund, T., Liu, Z., Petranovic, D., Nielsen, J., 2013. Heat shock response
improves heterologous protein secretion in Saccharomyces cerevisiae. Appl.
Microbiol. Biotechnol. 97 (8), 3559–3568.
Hou, J., Tang, H., Liu, Z., Osterlund, T., Nielsen, J., Petranovic, D., 2014. Management
of the endoplasmic reticulum stress by activation of the heat shock response in
yeast. FEMS Yeast Res. 14 (3), 481–494.
Huang, M., Bao, J., Nielsen, J., 2014. Biopharmaceutical protein production by Sac-
charomyces cerevisiae: current state and future prospects. Pharm. Bioprocess. 2
(2), 167–182.
Keij, J.F., Bell-Prince, C., Steinkamp, J.A., 2000. Staining of mitochondrial membranes
with 10-nonyl acridine orange, MitoFluor green, and MitoTracker green is af-
fected by mitochondrial membrane potential altering drugs. Cytometry 39 (3),
203–210.
Liu, L., Martinez, J.L., Liu, Z., Petranovic, D., Nielsen, J., 2014. Balanced globin protein
expression and heme biosynthesis improve production of human hemoglobin
in Saccharomyces cerevisiae. Metab. Eng. 21, 9–16.
Liu, Z., Tyo, K.E., Martinez, J.L., Petranovic, D., Nielsen, J., 2012. Different expression
systems for production of recombinant proteins in Saccharomyces cerevisiae.
Biotechnol. Bioeng. 109 (5), 1259–1268.
J.L. Martínez et al. / Metabolic Engineering Communications 3 (2016) 205–210210Liu, Z., Hou, J., Martinez, J.L., Petranovic, D., Nielsen, J., 2013. Correlation of cell
growth and heterologous protein production by Saccharomyces cerevisiae. Appl.
Microbiol. Biotechnol. 97 (20), 8955–8962.
Martinez, J.L., Liu, L., Petranovic, D., Nielsen, J., 2012. Pharmaceutical protein pro-
duction by yeast: towards production of human blood proteins by microbial
fermentation. Curr. Opin. Biotechnol. 23 (6), 965–971.
Martinez, J.L., Liu, L., Petranovic, D., Nielsen, J., 2015. Engineering the oxygen sen-
sing regulation results in an enhanced recombinant human hemoglobin pro-
duction by Saccharomyces cerevisiae. Biotechnol. Bioeng. 112 (1), 181–188.
Mattanovich, D., Branduardi, P., Dato, L., Gasser, B., Sauer, M., Porro, D., 2012. Re-
combinant protein production in yeasts. Methods Mol. Biol. 824, 329–358.
Millard, P.J., Roth, B.L., Thi, H.P., Yue, S.T., Haugland, R.P., 1997. Development of the
FUN-1 family of ﬂuorescent probes for vacuole labeling and viability testing of
yeasts. Appl. Environ. Microbiol. 63 (7), 2897–2905.
Nielsen, J., 2013. Production of biopharmaceutical proteins by yeast: advances
through metabolic engineering. Bioengineered 4 (4), 207–211.
Nolan, T., Hands, R.E., Bustin, S.A., 2006. Quantiﬁcation of mRNA using real-time RT-
PCR. Nat. Protoc. 1 (3), 1559–1582.
Porro, D., Gasser, B., Fossati, T., Maurer, M., Branduardi, P., Sauer, M., Mattanovich,
D., 2011. Production of recombinant proteins and metabolites in yeasts: when
are these systems better than bacterial production systems? Appl. Microbiol.
Biotechnol. 89 (4), 939–948.
Qin, Y., Lu, M., Gong, X., 2008. Dihydrorhodamine 123 is superior to 2,7-di-
chlorodihydroﬂuorescein diacetate and dihydrorhodamine 6G in detecting in-
tracellular hydrogen peroxide in tumor cells. Cell Biol. Int. 32 (2), 224–228.
Robinson, A.S., Hines, V., Wittrup, K.D., 1994. Protein disulﬁde isomerase over-
expression increases secretion of foreign proteins in Saccharomyces cerevisiae.
Biotechnol. 12 (4), 381–384.
Rozen, S., Skaletsky, H., 2000. Primer3 on the WWW for general users and for
biologist programmers. Methods Mol. Biol. 132, 365–386.
Ruijter, J.M., Ramakers, C., Hoogaars, W.M., Karlen, Y., Bakker, O., van den Hoff, M.J.,
Moorman, A.F., 2009. Ampliﬁcation efﬁciency: linking baseline and bias in theanalysis of quantitative PCR data. Nucleic Acids Res. 37 (6), e45.
Schefe, J.H., Lehmann, K.E., Buschmann, I.R., Unger, T., Funke-Kaiser, H., 2006.
Quantitative real-time RT-PCR data analysis: current concepts and the novel
“gene expression’s CT difference” formula. J. Mol. Med. 84 (11), 901–910.
Schroder, M., 2008. Engineering eukaryotic protein factories. Biotechnol. Lett. 30
(2), 187–196.
Sorensen, H.P., 2010. Towards universal systems for recombinant gene expression.
Microb. Cell Fact. 9, 27.
Ter Linde, J.J., Steensma, H.Y., 2002. A microarray-assisted screen for potential Hap1
and Rox1 target genes in Saccharomyces cerevisiae. Yeast 19 (10), 825–840.
Tu, B.P., Weissman, J.S., 2004. Oxidative protein folding in eukaryotes: mechanisms
and consequences. J. Cell Biol. 164 (3), 341–346.
Tu, B.P., Ho-Schleyer, S.C., Travers, K.J., Weissman, J.S., 2000. Biochemical basis of
oxidative protein folding in the endoplasmic reticulum. Science 290 (5496),
1571–1574.
Tyo, K.E., Liu, Z., Petranovic, D., Nielsen, J., 2012. Imbalance of heterologous protein
folding and disulﬁde bond formation rates yields runaway oxidative stress.
BMC Biol. 10, 16.
Udvardi, M.K., Czechowski, T., Scheible, W.R., 2008. Eleven golden rules of quanti-
tative RT-PCR. Plant Cell 20 (7), 1736–1737.
Wickham, H., 2009. Ggplot2: Elegant Graphics for Data Analysis. Springer, New
York.
Wittrup, K.D., Benig, V., 1994. Optimization of amino acid supplements for het-
erologous protein secretion in Saccharomyces cerevisiae. Biotechnol. Tech. 8 (3),
161–166.
Yu, J., Jiang, J., Fang, Z., Li, Y., Lv, H., Liu, J., 2010. Enhanced expression of hetero-
logous inulinase in Kluyveromyces lactis by disruption of hap1 gene. Bio-
technol. Lett. 32 (4), 507–512.
Zhang, L., Hach, A., 1999. Molecular mechanism of heme signaling in yeast: the
transcriptional activator Hap1 serves as the key mediator. Cell Mol. Life Sci. 56
(5–6), 415–426.
